Rchr
J-GLOBAL ID:201901006445340174   Update date: Nov. 05, 2024

Hiwatari Mitsuteru

ヒワタリ ミツテル | Hiwatari Mitsuteru
Affiliation and department:
Job title: lecturer
Research field  (1): Tumor biology
Research theme for competitive and other funds  (6):
  • 2024 - 2027 Analysis for the mechanism of tumorigenesis with ALK gene abnormality and establishment of a novel therapeutic approach in advanced neuroblastoma
  • 2020 - 2023 Integrated analysis of mechanisms of genetic susceptibility to cancer and clonal evolution in pediatric cancer
  • 2020 - 2023 Identification for oncogenic target and establishment of novel therapy for refractory leukemia or neuroblastoma
  • 2019 - 2021 Investigation for hidden cancer predisposition in pediatric cancer
  • 2016 - 2019 STAT3 inhibitor, cucurbitacin I, exerts growth-suppressive effects against neuroblastoma cells
Show all
Papers (77):
  • Nao Takasugi, Kaname Uchida, Konomi Shimoda, Eiichiro Watanabe, Shota Kato, Mitsuteru Hiwatari, Mahoko Ikeda, Motohiro Kato, Hikoro Matsui. Management of fulminant botulism after allogeneic hematopoietic cell transplantation. Pediatric Blood & Cancer. 2024
  • Yoshiaki Goto, Fumi Higuchi, Mitsuteru Hiwatari, Yuko Sasajima, Masahiro Shin. Endoscopic Endonasal Transsphenoidal Surgery for Intrasellar Mixed Germ Cell Tumors. World Neurosurgery. 2024
  • Kentaro Watanabe, Keiji Tasaka, Hideto Ogata, Shota Kato, Hiroo Ueno, Katsutsugu Umeda, Tomoya Isobe, Yasuo Kubota, Masahiro Sekiguchi, Shunsuke Kimura, et al. Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer Gene Therapy. 2024
  • Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, et al. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood Advances. 2024
  • 中村 こずえ, 樋渡 光輝, 新戸 瑞穂, 佐藤 恭弘, 小山 隆之, 三牧 正和, 内山 徹, 石黒 精. 免疫性血小板減少症との鑑別診断を必要とした先天性血小板減少症の1例. 日本小児血液・がん学会雑誌. 2023. 60. 3. 266-269
more...
MISC (236):
  • 中村こずえ, 中村こずえ, 樋渡光輝, 新戸瑞穂, 佐藤恭弘, 小山隆之, 三牧正和, 内山徹, 石黒精. A case of inherited thrombocytopenia required a differential diagnosis of immune thrombocytopenia. 日本小児血液・がん学会雑誌(Web). 2023. 60. 3
  • 中村こずえ, 中村こずえ, 樋渡光輝, 小山隆之, 後藤芳明, 三牧正和. A case with chronic autoimmune hemolytic anemia developed prolactinoma 11 years after diagnosis. 日本小児血液・がん学会雑誌(Web). 2023. 60. 4
  • 大漉優子, 中嶋祥平, 竹内文香, 木村真侑子, 布間瞳美, 佐竹和代, 佐藤伊織, 上別府圭子, 樋渡光輝. GVHD score and worries of patients undergoing outpatient follow-up after pediatric HSCT. 日本造血細胞移植学会総会プログラム・抄録集. 2021. 43rd
  • 三谷 友一, 関 正史, 鬼澤 真実, 日高 もえ, 藤村 純也, 樋渡 光輝, 滝田 順子. IST不応の小児最重症再生不良性貧血に対する臍帯血移植例. 日本小児血液・がん学会雑誌. 2019. 56. 3. 338-342
  • 大瀬戸 久美子, 樋渡 光輝, 星野 論子, 高柳 俊作, 吉田 俊太郎, 小林 寛, 田代 真理, 田中 敏明, 槙田 紀子, 田辺 真彦, et al. ゲノム医療に向けたチームでの取り組み 小児期発症の可能性のある遺伝性腫瘍に対する課題について. 日本癌治療学会学術集会抄録集. 2019. 57回. WS9-4
more...
Education (1):
  • 2001 - 2005 The University of Tokyo Graduate School of Medicine Reproductive, Developmental and Aging Sciences
Professional career (1):
  • Ph. D. (The University of Tokyo)
Work history (10):
  • 2022/04 - 現在 Teikyo University Teikyo University Hospital, Deopartment of Pediatrics lecturer
  • 2015/08 - 2022/03 The University of Tokyo Faculty of Medicine University Hospital, Department of Cell Therapy and Transplantation Medicine lecturer
  • 2010/04 - 2015/07 The University of Tokyo Faculty of Medicine University Hospital Department of Pediatrics Assistant professor
  • 2009/01 - 2010/03 Ohta Nishinouchi Hospital Department of Pediatrics Staff Doctor
  • 2005/04 - 2008/12 St. Jude Children's Research Hospital Department of Pathology Post. doc
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page